Inspire Medical Systems - INSP Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" INSP shares.
View INSP analyst ratings or view top-rated stocks.

6 equities research analysts have issued 12-month price targets for Inspire Medical Systems' stock. Their INSP share price forecasts range from $270.00 to $330.00. On average, they predict the company's share price to reach $303.00 in the next year. This suggests a possible upside of 22.1% from the stock's current price.
View analysts price targets for INSP or view top-rated stocks among Wall Street analysts.

Inspire Medical Systems' stock was trading at $251.88 at the start of the year. Since then, INSP stock has decreased by 1.5% and is now trading at $248.08.
View the best growth stocks for 2023 here.

Inspire Medical Systems saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 1,030,000 shares, a decline of 15.6% from the February 13th total of 1,220,000 shares. Based on an average daily volume of 293,100 shares, the short-interest ratio is currently 3.5 days.
View Inspire Medical Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our INSP earnings forecast.

Inspire Medical Systems, Inc. (NYSE:INSP) issued its earnings results on Tuesday, February, 7th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.54) by $0.64. The business had revenue of $137.90 million for the quarter, compared to the consensus estimate of $137.75 million. Inspire Medical Systems had a negative net margin of 11.00% and a negative trailing twelve-month return on equity of 12.66%. Inspire Medical Systems's revenue was up 75.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.09) EPS.

ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include Innovator IBD 50 ETF (FFTY), Fidelity Digital Health ETF (FDHT), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Principal Healthcare Innovators ETF (BTEC), Harbor Health Care ETF (MEDI), Global X Founder-Run Companies ETF (BOSS), Franklin Intelligent Machines ETF (IQM) and SPDR S&P Health Care Equipment ETF (XHE).

Inspire Medical Systems issued an update on its FY 2023 earnings guidance on Tuesday, February, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $560.00 million-$570.00 million, compared to the consensus revenue estimate of $541.57 million.

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

Inspire Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (3.72%), Macquarie Group Ltd. (3.65%), William Blair Investment Management LLC (2.88%), Gilder Gagnon Howe & Co. LLC (1.86%), Fred Alger Management LLC (1.77%) and Geode Capital Management LLC (1.75%). Insiders that own company stock include Casey M Tansey, Chau Quang Khuong, Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Orbimed Advisors Llc, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich, Timothy P Herbert and Timothy P Herbert.
View institutional ownership trends.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of INSP stock can currently be purchased for approximately $248.08.

Inspire Medical Systems (NYSE:INSP) has a market capitalization of $7.21 billion and generates $407.86 million in revenue each year. The company earns $-44,880,000.00 in net income (profit) each year or ($1.64) on an earnings per share basis.

The company employs 485 workers across the globe.

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The official website for the company is www.inspiresleep.com. The company can be reached via phone at (844) 672-4357 or via email at inspire@lifesciadvisors.com.